Analyst Price Target is $6.25
▲ +5,108.33% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for 22nd Century Group in the last 3 months. The average price target is $6.25, with a high forecast of $7.50 and a low forecast of $5.00. The average price target represents a 5,108.33% upside from the last price of $0.12.
Current Consensus is
Moderate Buy
The current consensus among 4 polled investment analysts is to moderate buy stock in 22nd Century Group. This Moderate Buy consensus rating has held steady for over two years.
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Read More